Aktive Positionen von Craig M. van de Mark
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
ZZ Biotech LLC
 ZZ Biotech LLC BiotechnologyHealth Technology ZZ Biotech LLC operates as a clinical stage company. It develops biologic treatments for ischemic stroke and other neurological diseases and wound healing applications including the treatment of diabetic foot ulcers. The firm mainly focuses on developing 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Institute. The company was founded by Selim Zilkha and Berislav V. Zlokovic in 2006 and is headquartered in Houston, TX. | Direktor/Vorstandsmitglied | - | - |
| General Counsel | - | - |
Karriereverlauf von Craig M. van de Mark
Statistik
International
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 1 |
| General Counsel | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
ZZ Biotech LLC
ZZ Biotech LLC BiotechnologyHealth Technology ZZ Biotech LLC operates as a clinical stage company. It develops biologic treatments for ischemic stroke and other neurological diseases and wound healing applications including the treatment of diabetic foot ulcers. The firm mainly focuses on developing 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Institute. The company was founded by Selim Zilkha and Berislav V. Zlokovic in 2006 and is headquartered in Houston, TX. | Health Technology |
- Börse
- Insiders
- Craig M. van de Mark
- Erfahrung
